Reimagining preclinical trials: Marmosets as model systems for the study of Alzheimer's disease

South Africa News News

Reimagining preclinical trials: Marmosets as model systems for the study of Alzheimer's disease
South Africa Latest News,South Africa Headlines
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 40 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 51%

To reimagine existing preclinical trials for Alzheimer's disease, University of Pittsburgh School of Medicine neuroscientists created the first non-human primate model of hereditary Alzheimer's in marmoset monkeys, outlining their approach in Alzheimer's & Dementia: Translational Research & Clinical Interventions.

Marmoset models bridge the current translation gap between human studies and cell and rodent models of AD. Establishment of marmoset models of aging and genetic risk loci for AD will enable robust and reliable mapping of cognitive and molecular outcomes across species. AD, Alzheimer's disease.

If allowed to age naturally, marmosets will spontaneously develop aggregates of toxic amyloid beta and tau indicative of Alzheimer's-like pathology in the brain. To create marmosets with inheritable predisposition to Alzheimer's disease, researchers introduced a series of mutations in the PSEN1 gene using the Crispr/Cas9 gene engineering system. These same mutations cause early onset Alzheimer's disease in humans.

Presenilin-1, the protein encoded by PSEN1, plays a key role in generating amyloid tangles, and, just like, marmosets with a mutation in the PSEN1 gene start developing Alzheimer's-like pathologies during adolescence. In establishing the model, the team is applying a bench-to-bedside approach to marmosets as though they were human patients.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

medical_xpress /  🏆 101. in UK

South Africa Latest News, South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Gary Wright dies at 80 after Parkinson's and Alzheimer's struggleGary Wright dies at 80 after Parkinson's and Alzheimer's struggleGary Wright, the musician known for the 1976 hit Dream Weaver and major work on former Beatle George Harrison's greatest solo album, has died at the age of 80.
Read more »

Swindon Alzheimer's singing group stars in Tony Christie music videoSwindon Alzheimer's singing group stars in Tony Christie music videoActor Nick Moran said the singing group brings his mother, who has dementia, 'a lot of joy'.
Read more »

Scientists discover new cause of Alzheimer's, vascular dementiaScientists discover new cause of Alzheimer's, vascular dementiaResearchers have discovered a new avenue of cell death in Alzheimer's disease and vascular dementia.
Read more »

OHSU scientists discover new avenue of cell death in Alzheimer's disease and vascular dementiaOHSU scientists discover new avenue of cell death in Alzheimer's disease and vascular dementiaResearchers have discovered a new avenue of cell death in Alzheimer's disease and vascular dementia.
Read more »

Researchers uncover new genetic traits influencing Alzheimer's riskResearchers uncover new genetic traits influencing Alzheimer's riskResearchers at the University of Pittsburgh analyzed thousands of human genomes to find new gene variations responsible for controlling the levels of blood plasma molecules linked to Alzheimer's disease risk. The findings, published recently in Molecular Psychiatry, could contribute to the future development of simple blood tests for the disease.
Read more »

Gary Wright dies at 80 after Parkinson's and Alzheimer's struggleGary Wright dies at 80 after Parkinson's and Alzheimer's struggleGary Wright, the musician known for the 1976 hit Dream Weaver and major work on former Beatle George Harrison's greatest solo album, has died at the age of 80.
Read more »



Render Time: 2025-03-04 22:37:28